Oxbridge Re (OXBR) Reports In-Line Q3 EPS

Oxbridge Re (NASDAQ: OXBR) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $640 thousand versus the consensus estimate of $700 thousand.

For earnings history and earnings-related data on Oxbridge Re (OXBR) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
• After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ